Journal Article10.1016/S0026-0495(97)90212-2
Glucose intolerance is associated with altered calcium homeostasis: a possible link between increased serum calcium concentration and cardiovascular disease mortality
Nicholas J. Wareham,Nicholas J. Wareham,Christopher D. Byrne,Christopher D. Byrne,Colin Carr,Colin Carr,Nicholas E. Day,Nicholas E. Day,Barbara J. Boucher,Barbara J. Boucher,C. Nicholas Hales,C. Nicholas Hales +11 more
114
TL;DR: Data suggest that IGT is associated with an increase in both total serum calcium and PTH that cannot be explained by confounding by aging, obesity, or 25OHD, and this relationship may explain the previously observed association between serumcium and cardiovascular mortality.
read more
Abstract: Serum calcium concentration has recently been shown to predict cardiovascular mortality in a large health-screening program. Since impaired glucose tolerance (IGT) is an independent cardiovascular risk factor, we examined the association between glucose intolerance and serum calcium in a population-based cohort study. To characterize this association, we measured total serum calcium, parathyroid hormone (PTH), 25-hydroxyvitamin D (25OHD), and 1,25-dihydroxyvitamin D (1,25-(OH)2D) levels in a cohort of 1,071 randomly selected white individuals aged 40 to 65 years in whom an oral glucose tolerance test had been completed. In multivariate analyses, the 2-hour plasma glucose was positively associated with increasing total serum calcium and PTH in men and women after adjustment for age, obesity, season, and 25OHD. The adjusted odds ratio (OR) between increasing quintiles of total serum calcium and IGT was 1.63 (95% confidence interval [CI], 1.42 to 1.88). The OR comparing the top with the bottom quintile was 8.5 (95% CI, 4.5 to 16.0). The association with quintile of serum PTH was 1.30 (95% CI, 1.14 to 1.49). These data suggest that IGT is associated with an increase in both total serum calcium and PTH that cannot be explained by confounding by aging, obesity, or 25OHD. This relationship may explain the previously observed association between serum calcium and cardiovascular mortality. Whether this association is a manifestation of a shared cellular defect or represents a common relationship with an unknown etiologic factor are important questions for further research.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Bone and mineral disorders in pre-dialysis CKD
TL;DR: The available literature on outcomes associated with bone and mineral disorders in patients with CKD not yet receiving maintenance dialysis is summarized and novel data linking fibroblast growth factor 23 to phosphorus and vitamin D homeostasis is reviewed.
Calcium and Vitamin D Supplementation During Androgen Deprivation Therapy for Prostate Cancer: A Critical Review
Mridul Datta,Gary G. Schwartz +1 more
TL;DR: The doses of calcium and vitamin D that have been tested are inadequate to prevent loss of bone mineral density in men undergoing androgen deprivation therapy.
75
Parathyroid hormone induces adipocyte lipolysis via PKA-mediated phosphorylation of hormone-sensitive lipase.
TL;DR: The results show that the lipolytic action of PTH is mediated by the PKA signaling pathway with no or minor contribution of other signaling pathways and, furthermore, that the Lipolyticaction of P TH is limited by simultaneous activation of PDE4.
71
Use of vitamin D in chronic kidney disease patients
TL;DR: The role of vitamin D administration in the different CKD stages will be discussed and the current K/DOQI and KDIGO recommendations limit the administration of VDRa agents for treatment of hyperparathyroidism only.
67
Serum 25-hydroxyvitamin D levels and the metabolic syndrome in older persons: a population-based study.
Mirjam M. Oosterwerff,Elisabeth M. W. Eekhoff,Martijn W. Heymans,Paul Lips,Natasja M. van Schoor +4 more
TL;DR: This data indicates that a lower plasma level of 25‐hydroxyvitamin D (25 OHD) is associated with a higher risk of the metabolic syndrome, but this research has not studied in older people with a high prevalence of vitamin D insufficiency.
59
References
•Book
Methods of Enzymatic Analysis
Hans Ulrich Bergmeyer
- 01 Jan 1963
TL;DR: Methods of enzymatic analysis, Methods of enzymes analysis, the authors, Methods of enzyme analysis, enzymatics, methods of enzymes, and methods of analysis, method of enzymes.
21.1K
Compendium of physical activities: classification of energy costs of human physical activities.
Barbara E. Ainsworth,William L. Haskell,Arthur S. Leon,David R. Jacobs,Henry J. Montoye,James F. Sallis,Ralph S. Paffenbarger +6 more
TL;DR: In this article, a coding scheme for classifying physical activity by rate of energy expenditure, i.e., by intensity, was presented for classification of physical activity using five digits that classify activity by purpose (i.e. sports, occupation, sel
4.2K
Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis.
C. N. Hales,David J.P. Barker +1 more
TL;DR: It is proposed that one of the major long-term consequences of inadequate early nutrition is impaired development of the endocrine pancreas and a greatly increased susceptibility to the development of Type 2 diabetes.
Reproducibility and Validity of a Self-Administered Physical Activity Questionnaire
Anne M. Wolf,David J. Hunter,David J. Hunter,Graham A. Colditz,Graham A. Colditz,JoAnn E. Manson,Meir J. Stampfer,Meir J. Stampfer,Karen A. Corsano,Bernard Rosner,Bernard Rosner,Andrea M. Kriska,Walter C. Willett,Walter C. Willett +13 more
TL;DR: The simple, short questionnaires on activity and inactivity used in the Nurses' Health Study II are reasonably valid measures for epidemiological research.
1K
Vitamin D deficiency inhibits pancreatic secretion of insulin
TL;DR: An important role for vitamin D in the endocrine functioning of the pancreas is indicated by the previously demonstrated presence of a vitamin D-dependent calcium-binding protein and cytosol receptor for the hormonal form of vitamin D, 1,25-dihydroxyvitamin D3.
766